The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
High Frequencies of Naive Melan-a/Mart-1–Specific Cd8+ T Cells in a Large Proportion of Human Histocompatibility Leukocyte Antigen (Hla)-A2 Individuals
Open accessAbstract
Using fluorescent HLA-A*0201 tetramers containing the immunodominant Melan-A/MART-1 (Melan-A) tumor-associated antigen (Ag), we previously observed that metastatic lymph nodes of melanoma patients contain high numbers of Ag-experienced Melan-A–specific cytolytic T lymphocytes (CTLs). In this paper, we enumerated and characterized ex vivo Melan-A–specific cells in peripheral blood samples from both melanoma patients and healthy individuals. High frequencies (≥1 in 2,500 CD8+ T cells) of Melan-A–specific cells were found in 10 out of 13 patients, and, surprisingly, in 6 out of 10 healthy individuals. Virtually all Melan-A–specific cells from 6 out of 6 healthy individuals and from 7 out of 10 patients displayed a naive CD45RAhi/RO− phenotype, whereas variable proportions of Ag-experienced CD45RAlo/RO+ Melan-A–specific cells were observed in the remaining 3 patients. In contrast, ex vivo influenza matrix–specific CTLs from all individuals exhibited a CD45RAlo/RO+ memory phenotype as expected. Ag specificity of tetramer-sorted A2/Melan-A+ cells from healthy individuals was confirmed after mitogen-driven expansion. Likewise, functional limiting dilution analysis and interferon γ ELISPOT assays independently confirmed that most of the Melan-A–specific cells were not Ag experienced. Thus, it appears that high frequencies of naive Melan-A–specific CD8+ T cells can be found in a large proportion of HLA-A*0201+ individuals. Furthermore, as demonstrated for one patient followed over time, dramatic phenotype changes of circulating Melan-A–specific cells can occur in vivo.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Phenotypic Analysis of Antigen-Specific T Lymphocytes
Altman, J. D., Moss, P. A. H., Goulder, P. J. R., Barouch, D. H., McHeyzer-Williams, M. G., Bell, J. I., McMichael, A. J., & Davis, M. M. (1996) · Science · doi:10.1126/science.274.5284.94 · Cited by 3,544 · cited 1×
“Since the majority of HLAA * 0201 individuals are sensitized against the latter immunodominant peptide (25), it served as a source of welldefined memory-type, epitope-specific CTL populations in circulating lymphocytes (26).”
BackgroundSivia, D. S. (1996) · Cited by 2,678
Phenotypic and functional separation of memory and effector human CD8+ T cells
Hamann, D., Baars, P. A., Rep, M. H. G., Hooibrink, B., Kerkhof-Garde, S. R., Klein, M. R., & Lier, R. A. W. V. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.186.9.1407 · Cited by 1,366
Taswell, C. (1981) · The Journal of Immunology · doi:10.4049/jimmunol.126.4.1614 · Cited by 1,212
Kawakami, Y., Eliyahu, S., Delgado, C. H., Robbins, P. F., Rivoltini, L., Topalian, S. L., Miki, T., & Rosenberg, S. A. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.9.3515 · Cited by 1,092
Coulie, P. G., Brichard, V, Van Pel, A., Wölfel, T., Schneider, J., Traversari, C., Mattei, S., De Plaen, E., Lurquin, C., Szikora, J. P., et al. (1994) · The Journal of experimental medicine · doi:10.1084/jem.180.1.35 · Cited by 903
Dutton, R. W., Bradley, L. M., & Swain, S. L. (1998) · Annual Review of Immunology · doi:10.1146/annurev.immunol.16.1.201 · Cited by 832
Antigen-independent activation of naive and memory resting T cells by a cytokine combination.
Unutmaz, D., Pileri, P., & Abrignani, S. (1994) · The Journal of experimental medicine · doi:10.1084/jem.180.3.1159 · Cited by 524
Romero, P., Rod Dunbar, P., Valmori, D., Pittet, M., Ogg, G. S., Rimoldi, D., Chen, J.-L., Liénard, D., Cerottini, J.-C., & Cerundolo, V. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.9.1641 · Cited by 521
Self-citationCD8 naive T cell counts decrease progressively in HIV-infected adults.
Roederer, M., Dubs, J. G., Anderson, M. T., Raju, P. A., Herzenberg, L. A., & Herzenberg, L. A. (1995) · Journal of Clinical Investigation · doi:10.1172/jci117892 · Cited by 489
Valmori, D., Fonteneau, J.-F., Lizana, C. M., Gervois, N., Liénard, D., Rimoldi, D., Jongeneel, V., Jotereau, F., Cerottini, J.-C., & Romero, P. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.160.4.1750 · Cited by 483
Self-citationHigh Frequency of Skin-homing Melanocyte-specific Cytotoxic T Lymphocytes in Autoimmune Vitiligo
Ogg, G. S., Rod Dunbar, P., Romero, P., Chen, J.-L., & Cerundolo, V. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.6.1203 · Cited by 460
Self-citationPardoll, D. M. (1998) · Nature Medicine · doi:10.1038/nm0598supp-525 · Cited by 428
Skipper, J. C., Hendrickson, R. C., Gulden, P. H., Brichard, V, Van Pel, A., Chen, Y., Shabanowitz, J., Wolfel, T., Slingluff, C. L., Boon, T., et al. (1996) · The Journal of experimental medicine · doi:10.1084/jem.183.2.527 · Cited by 405
CD28- T lymphocytes. Antigenic and functional properties
Azuma, M., Phillips, J. H., & Lanier, L. L. (1993) · The Journal of Immunology · doi:10.4049/jimmunol.150.4.1147 · Cited by 387
Expansion of cytotoxic CD8 + CD28 − T cells in healthy ageing people, including centenarians
FAGNONI, F. F., VESCOVINI, R., MAZZOLA, M., BOLOGNA, G., NIGRO, E., LAVAGETTO, G., FRANCESCHI, C., PASSERI, M., & SANSONI, P. (1996) · Immunology · doi:10.1046/j.1365-2567.1996.d01-689.x · Cited by 362
Vitiligo in Patients with Melanoma: Normal Tissue Antigens Can Be Targets for Cancer Immunotherapy
Rosenberg, S. A., & White, D. E. (1996) · Journal of Immunotherapy · doi:10.1097/00002371-199601000-00009 · Cited by 333
Parham, P., & Brodsky, F. M. (1981) · Human Immunology · doi:10.1016/0198-8859(81)90065-3 · Cited by 320
Rivoltini, L., Kawakami, Y., Sakaguchi, K., Southwood, S., Sette, A., Robbins, P. F., Marincola, F. M., Salgaller, M. L., Yannelli, J. R., Appella, E., et al. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.154.5.2257 · Cited by 290
Vitiligo in patients with metastatic melanoma: A good prognostic sign
Nordlund, J. J., Kirkwood, J. M., Forget, B. M., Milton, G., Albert, D. M., & Lerner, A. B. (1983) · Journal of the American Academy of Dermatology · doi:10.1016/s0190-9622(83)70182-9 · Cited by 288
McMichael, A. J., & O'Callaghan, C. A. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.187.9.1367 · Cited by 263
Lehner, P. J., Wang, E. C., Moss, P. A., Williams, S., Platt, K., Friedman, S. M., Bell, J. I., & Borysiewicz, L. K. (1995) · The Journal of experimental medicine · doi:10.1084/jem.181.1.79 · Cited by 258
Human tumor antigens recognized by T cells
Robbins, P. (1996) · Current Opinion in Immunology · doi:10.1016/s0952-7915(96)80078-1 · Cited by 210
Posnett, D. N., Edinger, J. W., Manavalan, J. S., Irwin, C., & Marodon, G. (1999) · International Immunology · doi:10.1093/intimm/11.2.229 · Cited by 202
The role of tyrosinase in autoimmune vitiligo
Song, Y.-H., Connor, E., Li, Y., Zorovich, B., Balducci, P., & Maclaren, N. (1994) · The Lancet · doi:10.1016/s0140-6736(94)91709-4 · Cited by 197
CD4+ T-cell memory, CD45R subsets and the persistence of antigen—a unifying concept
Bell, E. B., Sparshott, S. M., & Bunce, C. (1998) · Immunology Today · doi:10.1016/s0167-5699(97)01211-5 · Cited by 196
Cyclic regulation of CD45 isoform expression in a long term human CD4+CD45RA+ T cell line
Rothstein, D. M., Yamada, A., Schlossman, S. F., & Morimoto, C. (1991) · The Journal of Immunology · doi:10.4049/jimmunol.146.4.1175 · Cited by 182
Loftus, D. J., Castelli, C., Clay, T. M., Squarcina, P., Marincola, F. M., Nishimura, M. I., Parmiani, G., Appella, E., & Rivoltini, L. (1996) · The Journal of experimental medicine · doi:10.1084/jem.184.2.647 · Cited by 180
Faces and phases of human CD8+ T-cell development
Hamann, D., Roos, M. T. L., & van Lier, R. A. W. (1999) · Immunology Today · doi:10.1016/s0167-5699(99)01444-9 · Cited by 179
Romero, P., Gervois, N., Schneider, J., Escobar, P., Valmori, D., Pannetier, C., Steinle, A., Wolfel, T., Lienard, D., Brichard, V, et al. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.159.5.2366 · Cited by 168
Self-citationMerkenschlager, M., & Beverley, P. C. L. (1989) · International Immunology · doi:10.1093/intimm/1.4.450 · Cited by 139
MHC Class I Is Required for Peripheral Accumulation of CD8+ Thymic Emigrants
Nes̆ić, D., & Vukmanović, S. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.160.8.3705 · Cited by 118
de Jong, R., Brouwer, M. C., Miedema, F. F., & van Lier, R. A. W. (1991) · The Journal of Immunology · doi:10.4049/jimmunol.146.7.2088 · Cited by 112
Okumura, M., Fujii, Y., Inada, K., Nakahara, K., & Matsuda, H. (1993) · The Journal of Immunology · doi:10.4049/jimmunol.150.2.429 · Cited by 106
The organization of mature T-cell pools
Tanchot, C., & Rocha, B. (1998) · Immunology Today · doi:10.1016/s0167-5699(98)01344-9 · Cited by 102
Young, J. L., Ramage, J. M., Gaston, H., & Beverley, P. C. L. (1997) · European Journal of Immunology · doi:10.1002/eji.1830270937 · Cited by 92
Novel methods to monitor antigen-specific cytotoxic T-cell responses in cancer immunotherapy
Romero, P. J., Cerottini, J., & Waanders, G. A. (1998) · Molecular Medicine Today · doi:10.1016/s1357-4310(98)01280-5 · Cited by 84
Self-citationBerthou, C., Legros-Maïda, S., Soulié, A., Wargnier, A., Guillet, J., Rabian, C., Gluckman, É., & Sasportes, M. (1995) · Blood · doi:10.1182/blood.v85.6.1540.bloodjournal8561540 · Cited by 82
Valmori, D., Pittet, M. J., Vonarbourg, C., Rimoldi, D., Liénard, D., Speiser, D. E., Dunbar, P. R., Cerundolo, V., Cerottini, J. C., & Romero, P. J. (1999) · PubMed · Cited by 68
Self-citationD’Souza, S., Rimoldi, D., Líénard, D., Lejeune, F. J., Cerottini, J., & Romero, P. J. (1998) · International Journal of Cancer · Cited by 66
Self-citationAn antigen-targeted approach to adoptive transfer therapy of cancer.
Valmori, D., Pittet, M. J., Rimoldi, D., Líénard, D., Dunbar, P. R., Cerundolo, V., Lejeune, F. J., Cerottini, J., & Romero, P. J. (1999) · PubMed · Cited by 63
Self-citationAssessment of Immunogenicity of Human Melan-A Peptide Analogues in HLA-A*0201/Kb Transgenic Mice
Men, Y., Miconnet, I., Valmori, D., Rimoldi, D., Cerottini, J., & Romero, P. J. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.6.3566 · Cited by 60
Self-citationIdentical expression of CD45R isoforms by CD45RC+‘revertant’ memory and CD45RC+ naive CD4 T cells
Hargreaves, M., & Bell, E. B. (1997) · Immunology · doi:10.1046/j.1365-2567.1997.00267.x · Cited by 44
Cited by
Natural Innate and Adaptive Immunity to Cancer
Vesely, M. D., Kershaw, M. H., Schreiber, R. D., & Smyth, M. J. (2011) · Annual Review of Immunology · doi:10.1146/annurev-immunol-031210-101324 · Cited by 2,101
Fuertes, M. B., Kacha, A. K., Kline, J., Woo, S.-R., Kranz, D. M., Murphy, K. M., & Gajewski, T. F. (2011) · Journal of Experimental Medicine · doi:10.1084/jem.20101159 · Cited by 1,192
Tumour antigens recognized by T lymphocytes: at the core of cancer immunotherapy
Coulie, P. G., Van den Eynde, B. J., van der Bruggen, P., & Boon, T. (2014) · Nature Reviews Cancer · doi:10.1038/nrc3670 · Cited by 1,138
CD8+ T cell differentiation and dysfunction in cancer
Philip, M., & Schietinger, A. (2022) · Nature Reviews Immunology · doi:10.1038/s41577-021-00574-3 · Cited by 1,052
Sutmuller, R. P. M., van Duivenvoorde, L. M., van Elsas, A., Schumacher, T. N. M., Wildenberg, M. E., Allison, J. P., Toes, R. E. M., Offringa, R., & Melief, C. J. M. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.194.6.823 · Cited by 1,008
Metadata
- Authors
- Pittet, M. J., Valmori, D., Dunbar, P. R., Speiser, D. E., Liénard, D., Lejeune, F., Fleischhauer, K., Cerundolo, V., Cerottini, J.-C., & Romero, P.
- Venue
- The Journal of Experimental Medicine
- Publisher
- Rockefeller University Press
- Published
- 1999-09-06
- Volume
- 190
- Issue
- 5
- Pages
- 705-716
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- OpenAlex
- W2167008563
- Cited by
- 508
- References
- 43
- FWCI
- 12.71
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.